title: Treatment of central venous catheter-associated deep venous thrombosis in cancer patients with rivaroxaban.
authors.affiliation: Hematology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Eva S
authors.initials: ES
authors.lastname: Laube
authors.affiliation: Hematology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Simon
authors.initials: S
authors.lastname: Mantha
authors.affiliation: Division of Quality and Safety, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Patrick
authors.initials: P
authors.lastname: Samedy
authors.affiliation: Data Solution Group, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Wills
authors.affiliation: Pharmacy Department, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Stephen
authors.initials: S
authors.lastname: Harnicar
authors.affiliation: Hematology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Gerald A
authors.initials: GA
authors.lastname: Soff
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D012189:Retrospective Studies; D000069552:Rivaroxaban / Q000008:administration & dosage*; D056824:Upper Extremity Deep Vein Thrombosis / Q000188:drug therapy*
chemical_list: D000069552:Rivaroxaban